Roebi de Bruijn

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Ewa Gogola, Alexandra A. Duarte, Julian R. de Ruiter et al. · Cancer Cell · 2018 · 385 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Xing Yi Woo, Jessica Giordano, Anuj Srivastava et al. · Nature Genetics · 2021 · 191 citations · Full text

Medicine, Molecular Genetics, Oncology +15

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

Dario Zimmerli, Chiara Svetlana Brambillasca, Francien Talens et al. · Nature Communications · 2022 · 137 citations · Full text

Medicine, Immunology, Oncology +17

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko et al. · Nature · 2022 · 130 citations · Full text

Medicine, Genetics, Oncology +17

CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer

Julia M. Houthuijzen, Roebi de Bruijn, Eline van der Burg et al. · Nature Communications · 2023 · 114 citations · Full text

Medicine, Cell Biology, Oncology +17